NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Advanced KRASG12C-mutated non-small cell lung cancer subjects who previosly progressed on at least one prior line of therapy, or who have contraindications for immuno/chemotherapy.
1 total trials
Filter these 1 trials by phase, country, sponsor and more.